- WB
Supplier Data
Western blot - Anti-Patched / PTCH1 antibody [EPR26072-78] (AB325234)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative : HEL, 786-O.
PTCH1 is a glycosylated protein and can be deglycosylated by Protein Deglycosylation MIX II.
In Western blot, Anti-alpha Actinin 4 antibody [EPR2533 (2)] - Loading Control (ab108198) staining at 1/100,000 dilution.
All lanes:
Western blot - Anti-Patched / PTCH1 antibody [EPR26072-78] (ab325234) at 1/1000 dilution
Lane 1:
Untreated 22Rv1 (human prostate carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
22Rv1 whole cell lysate treated with Protein Deglycosylation MIX II at 20 µg
Lane 3:
HEL (human erythroleukemia erythroblast) whole cell lysate at 20 µg
Lane 4:
786-O (human kidney epithelial cell) whole cell lysate at 20 µg
Lane 5:
IMR-32 (human neuroblastoma neuroblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 160-180 kDa,105 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Patched / PTCH1 antibody [EPR26072-78] (AB325234)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-Vinculin antibody [EPR8185] - (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Patched / PTCH1 antibody [EPR26072-78] (ab325234) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) transfected with an empty vector containing a myc-His-tag® whole cell lysate at 10 µg
Lane 2:
293T transfected with PTCH1 (WT) expression vector containing an EGFP-Myc-tag whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 160-180 kDa,124 kDa,200 kDa
false
Exposure time: 6s
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-Patched / PTCH1 antibody [EPR26072-78] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com